1. Home
  2. MAIA vs ARBK Comparison

MAIA vs ARBK Comparison

Compare MAIA & ARBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • ARBK
  • Stock Information
  • Founded
  • MAIA 2018
  • ARBK 2017
  • Country
  • MAIA United States
  • ARBK United Kingdom
  • Employees
  • MAIA N/A
  • ARBK N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • ARBK Finance: Consumer Services
  • Sector
  • MAIA Health Care
  • ARBK Finance
  • Exchange
  • MAIA Nasdaq
  • ARBK Nasdaq
  • Market Cap
  • MAIA 44.9M
  • ARBK 39.8M
  • IPO Year
  • MAIA 2022
  • ARBK 2021
  • Fundamental
  • Price
  • MAIA $1.11
  • ARBK $0.34
  • Analyst Decision
  • MAIA
  • ARBK Hold
  • Analyst Count
  • MAIA 0
  • ARBK 1
  • Target Price
  • MAIA N/A
  • ARBK N/A
  • AVG Volume (30 Days)
  • MAIA 747.3K
  • ARBK 2.9M
  • Earning Date
  • MAIA 11-07-2025
  • ARBK 11-12-2025
  • Dividend Yield
  • MAIA N/A
  • ARBK N/A
  • EPS Growth
  • MAIA N/A
  • ARBK N/A
  • EPS
  • MAIA N/A
  • ARBK N/A
  • Revenue
  • MAIA N/A
  • ARBK $24,043,000.00
  • Revenue This Year
  • MAIA N/A
  • ARBK $183.90
  • Revenue Next Year
  • MAIA N/A
  • ARBK $26.78
  • P/E Ratio
  • MAIA N/A
  • ARBK N/A
  • Revenue Growth
  • MAIA N/A
  • ARBK N/A
  • 52 Week Low
  • MAIA $1.05
  • ARBK $0.15
  • 52 Week High
  • MAIA $3.48
  • ARBK $1.55
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 34.52
  • ARBK 42.11
  • Support Level
  • MAIA $1.05
  • ARBK $0.31
  • Resistance Level
  • MAIA $1.35
  • ARBK $0.37
  • Average True Range (ATR)
  • MAIA 0.10
  • ARBK 0.05
  • MACD
  • MAIA -0.03
  • ARBK -0.02
  • Stochastic Oscillator
  • MAIA 12.85
  • ARBK 19.96

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About ARBK Argo Blockchain plc

Argo Blockchain PLC is a blockchain technology company focused on the large-scale mining of Bitcoin. It mines bitcoin using purpose-built computers (or mining machines) to solve complex cryptographic algorithms on the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company acquires and deploys mining technology solutions in North American facilities that utilize predominantly renewable and inexpensive electricity.

Share on Social Networks: